David R Spielberg1, Jeffrey S Barrett, Gregory B Hammer, David R Drover, Tammy Reece, Carol A Cohane, Scott R Schulman. 1. From the *Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina; †Department of Pediatrics, University of Pennsylvania Medical School, Philadelphia, Pennsylvania; ‡Department of Anesthesia, Stanford School of Medicine, Stanford, California; and §Duke Clinical Research Institute, Durham, North Carolina.
Abstract
BACKGROUND:Sodium nitroprusside (SNP) is used to decrease arterial blood pressure (BP) during certain surgical procedures. There are limited data regarding efficacy of BP control with SNP. There are no data on patient and clinician factors that affect BP control. We evaluated the dose-response relationship of SNP in infants and children undergoing major surgery and performed a quantitative assessment of BP control. METHODS:One hundred fifty-three subjects at 7 sites received ablinded infusion followed by open-label SNP during operative procedures requiring controlled hypotension. SNP was administered by continuous infusion and titrated to maintain BP control (mean arterial BP [MAP] within ±10% of clinician-defined target). BP was recorded using an arterial catheter. Statistical process control methodology was used to quantify BP control. A multivariable model assessed the effects of patient and procedural factors. RESULTS:BP was controlled an average 45.4% (SD 23.9%; 95% CI, 41.5%-49.18%) of the time. Larger changes in infusion rate were associated with worse BP control (7.99% less control for 1 μg·kg·min increase in average titration size, P = 0.0009). A larger difference between a patient's baseline and target MAP predicted worse BP control (0.93% worse control per 1-mm Hg increase in MAP difference, P = 0.0013). Both effects persisted in multivariable models. CONCLUSIONS:SNP was effective in reducing BP. However, BP was within the target range less than half of the time. No clinician or patient factors were predictive of BP control, although 2 inverse relationships were identified. These relationships require additional study and may be best coupled with exposure-response modeling to propose improved dosing strategies when using SNP for controlled hypotension in the pediatric population.
RCT Entities:
BACKGROUND:Sodium nitroprusside (SNP) is used to decrease arterial blood pressure (BP) during certain surgical procedures. There are limited data regarding efficacy of BP control with SNP. There are no data on patient and clinician factors that affect BP control. We evaluated the dose-response relationship of SNP in infants and children undergoing major surgery and performed a quantitative assessment of BP control. METHODS: One hundred fifty-three subjects at 7 sites received a blinded infusion followed by open-label SNP during operative procedures requiring controlled hypotension. SNP was administered by continuous infusion and titrated to maintain BP control (mean arterial BP [MAP] within ±10% of clinician-defined target). BP was recorded using an arterial catheter. Statistical process control methodology was used to quantify BP control. A multivariable model assessed the effects of patient and procedural factors. RESULTS: BP was controlled an average 45.4% (SD 23.9%; 95% CI, 41.5%-49.18%) of the time. Larger changes in infusion rate were associated with worse BP control (7.99% less control for 1 μg·kg·min increase in average titration size, P = 0.0009). A larger difference between a patient's baseline and target MAP predicted worse BP control (0.93% worse control per 1-mm Hg increase in MAP difference, P = 0.0013). Both effects persisted in multivariable models. CONCLUSIONS: SNP was effective in reducing BP. However, BP was within the target range less than half of the time. No clinician or patient factors were predictive of BP control, although 2 inverse relationships were identified. These relationships require additional study and may be best coupled with exposure-response modeling to propose improved dosing strategies when using SNP for controlled hypotension in the pediatric population.
Authors: S L Hersey; N E O'Dell; S Lowe; G Rasmussen; J D Tobias; J K Deshpande; G Mencio; N Green Journal: Anesth Analg Date: 1997-06 Impact factor: 5.108
Authors: Stewart J Lustik; Peter J Papadakos; Kenneth V Jackman; Paul T Rubery; Karen L Kaplan; Ashwani K Chhibber Journal: J Clin Anesth Date: 2004-02 Impact factor: 9.452
Authors: Jeffrey S Barrett; Sarapee Hirankarn; Nick Holford; Gregory B Hammer; David R Drover; Carol A Cohane; Brian Anderson; Erin Dombrowski; Tammy Reece; Anne Zajicek; Scott R Schulman Journal: Front Pharmacol Date: 2015-07-28 Impact factor: 5.810